[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366936-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366936-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","context-dependent-inhibitory-roles-of-rhoa-in-3d-invasive-cell-migration-within-the-extracellular-matrix","Context-dependent inhibitory roles of RhoA in 3D invasive cell migration within the extracellular matrix","","Cell migration drives physiological remodeling and cancer progression, and the small GTPase RHOA is studied here in 3D invasive movement. Non-cancerous HEK293, pancreatic PANC-1, and breast MDA-MB-231 cells were tested in distinct extracellular matrix environments to determine how RHOA loss alters invasion. Spheroid assays show enhanced migration for RHOA-deficient HEK293 and PANC-1 in Geltrex but not in type I collagen, with minimal effects in MDA-MB-231.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/context-dependent-inhibitory-roles-of-rhoa-in-3d-invasive-cell-migration-within-the-extracellular-matrix/366936/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/context-dependent-inhibitory-roles-of-rhoa-in-3d-invasive-cell-migration-within-the-extracellular-matrix/366936.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does RHOA loss affect 3D invasive migration in HEK293 and PANC-1 cells?","Question",{"text":63,"@type":64},"RHOA loss enhances spheroid invasion for HEK293 and PANC-1 cells in the Geltrex ECM environment. This enhancement is not observed when cells are cultured in type I collagen.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Does the impact of RHOA deletion depend on extracellular matrix composition?",{"text":68,"@type":64},"Yes. The study finds ECM-dependent effects: RHOA-deficient HEK293 and PANC-1 cells show increased migration in Geltrex but little change in type I collagen.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the in vivo consequence of RHOA knockout in pancreatic cancer progression?",{"text":72,"@type":64},"Although RHOA knockout increases 3D migration in cell-based assays, it reduces pancreatic tumor progression in a mouse model.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366936,1790652514,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Author Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Cell Rep. Author manuscript; available in PMC 2026 January 22. |\n| --- | --- |\n\nPublished in final edited form as:  \nCell Rep. 2025 December 23; 44(12): 116649. doi:10.1016/j.celrep.2025.116649 .  \nContext-dependent inhibitory roles of RhoA in 3D invasive cell migration within the extracellular matrix  \nWakiko Iwata 1 , Yoshihiro Adachi 1 , Junior J. West 1,8 , Andrew J. Ewald 1,2,3,4 , Yi Zheng5,6 , Laura D. Wood7 , Robert A. Anders7 , Hiromi Sesaki 1 , Miho Iijima 1,9,*  \n1 Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA  \n2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA  \n3Giovanis Institute for Translational Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA  \n4 Department of Biomedical Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, USA  \n5 Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA  \n6 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA  \n7 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA  \n8 Present address: Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA  \n9Lead contact  \nSUMMARY  \nCell migration is fundamental to both physiological and pathological processes, including cancer progression. This study investigates the role of the small GTPase RHOA in invasive cell migration within diverse 3D extracellular matrix (ECM) environments using non-cancerous HEK293, pancreatic cancer PANC-1, and breast cancer MDA-MB-231 cells. Spheroid invasion assays showed that RHOA loss enhanced migration in HEK293 and PANC-1 cells cultured in Geltrex but not in type I collagen. In contrast, RHOA deletion had little effect on MDA-MB-231 migration in either ECM. Enhanced migration in RHOA-deficient HEK293 cells required protein phosphatase PTP1B and the small GTPases RAC and CDC42 . Unexpectedly, while RHOA knockout increased 3D migration, it reduced pancreatic tumor progression in mice. These findings reveal that  \nThis is an open access article under the CC BY-NC-ND license ([https://creativecommons.org/licenses/by-nc-nd/4.0/](https://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*[Correspondence: miijima@jhmi.edu](Correspondence: miijima@jhmi.edu).  \nAUTHOR CONTRIBUTIONS  \nW.I., M.I., and H.S. designed the study. W.I., Y.A., J.J.W., and M.I. performed the experiments. W.I., Y.A., L.D.W., R.A.A., H.S., and  \nM.I. analyzed the data. Y.Z., H.S., and M.I. provided critical materials. M.I., W.I., Y.A., J.J.W., L.D.W., R.A.A., A.J.E., and H.S. wrote or reviewed the manuscript.  \nDECLARATION OF INTERESTS  \nA.J.E. has unlicensed patents related to keratin 14 as a prognostic marker and antibody strategy for anti-cancer therapeutics. A.J.E. is a consultant for BioNTech. A.J.E.’s spouse is an employee of ImmunoCore.  \nAuthor Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \nIwata et al. Page 2  \nRHOA regulates cell invasion in a manner dependent on ECM composition and cellular context, highlighting its complex, context-specific roles and potential as a therapeutic target in cancer.  \nIn brief  \nIwata et al. show that the small GTPase RHOA regulates cell invasion in 3D environments,  \nwith effects shaped by ECM composition and cellular context. They demonstrate that RHOA knockout slows pancreatic tumor progression in a mouse model, highlighting unique opportunities for therapeutic strategies targeting RHOA in cancer.  \nGraphical Abstract  \nINTRODUCTION  \nCell migration is a fundamental biological process essential for various physiological and pathological events, includin","cbCaigkfS1Fw4iZp","https://ap.wps.com/l/cbCaigkfS1Fw4iZp","pdf",3495470,35,"English","# Summary\n## Cell migration and RHOA context in 3D ECM\n## Experimental design: cell types and ECMs\n## Key findings: ECM-dependent RHOA effects\n## In vivo relevance in pancreatic tumor progression\n# Graphical Abstract\n# Introduction\n## RHOA and cytoskeletal regulation\n## 3D spheroid ECM models and invasion relevance\n## Study aims and approach","[{\"question\":\"How does RHOA loss affect 3D invasive migration in HEK293 and PANC-1 cells?\",\"answer\":\"RHOA loss enhances spheroid invasion for HEK293 and PANC-1 cells in the Geltrex ECM environment. This enhancement is not observed when cells are cultured in type I collagen.\"},{\"question\":\"Does the impact of RHOA deletion depend on extracellular matrix composition?\",\"answer\":\"Yes. The study finds ECM-dependent effects: RHOA-deficient HEK293 and PANC-1 cells show increased migration in Geltrex but little change in type I collagen.\"},{\"question\":\"What is the in vivo consequence of RHOA knockout in pancreatic cancer progression?\",\"answer\":\"Although RHOA knockout increases 3D migration in cell-based assays, it reduces pancreatic tumor progression in a mouse model.\"}]","Context-dependent inhibitory roles of RhoA in 3D invasive cell migration within the extracellular matrix | PDF",1790168294,88,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c3e48f43e71e644196313891ca2d9ba.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2ae293d4af4da607d56a29e6303dfcd.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfca15e620608fd63ad06478de572395.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/408715e2e219720f26d7d2ab97078498.webp",980,1268]